Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction
Open Access
- 25 January 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 123 (3), 274-281
- https://doi.org/10.1161/circulationaha.110.963181
Abstract
Background—: The safety of drug-eluting stents in ST-segment elevation myocardial infarction (STEMI) continues to be debated. Pathological studies have demonstrated an association between uncovered struts and subsequent stent thrombosis. Optical coherence tomography can detect stent strut coverage in vivo on a micron-scale level. We therefore used optical coherence tomography to examine strut coverage in patients with STEMI treated with paclitaxel-eluting stents (PES) and bare metal stents (BMS). Methods and Results—: In the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, patients with STEMI were randomized 3:1 to PES or BMS implantation. In a formal substudy, optical coherence tomography at 13 months was performed in 118 consecutive randomized patients (89 PES, 29 BMS) in whom 188 stents were assessed (146 PES and 42 BMS). A total of 44 139 stent struts were analyzed by an independent core laboratory blinded to stent assignment. The primary prespecified end point, the percentage of uncovered stent struts per lesion at follow-up, was 1.1±2.5% in BMS lesions versus 5.7±7.0% in PES lesions ( P P =0.0003). Percentage net volume obstruction was 36.0±15.4% with BMS and 19.2±11.3% with PES ( P <0.0001). Conclusions—: In patients with STEMI undergoing primary percutaneous coronary intervention, implantation of PES as compared with BMS significantly reduces neointimal hyperplasia but results in higher rates of uncovered and malapposed stent struts as assessed by optical coherence tomography at 13-month follow-up. Further studies are required to determine the clinical significance of these findings. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00433966.Keywords
This publication has 29 references indexed in Scilit:
- Accuracy of Optical Coherence Tomography in the Evaluation of Neointimal Coverage After Stent ImplantationJACC: Cardiovascular Imaging, 2010
- An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-studyEuropean Heart Journal, 2009
- Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial InfarctionNew England Journal of Medicine, 2009
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction PatientsCirculation, 2008
- Optical coherence tomography: High resolution intravascular imaging to evaluate vascular healing after coronary stentingCatheterization and Cardiovascular Interventions, 2008
- In Vivo Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Detecting Small Degrees of In-Stent Neointima After Stent ImplantationJACC: Cardiovascular Interventions, 2008
- Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEuropean Heart Journal, 2007
- Vascular Responses to Drug Eluting StentsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Pathology of Drug-Eluting Stents in HumansJournal of the American College of Cardiology, 2006